PMID- 34222184 OWN - NLM STAT- MEDLINE DCOM- 20210804 LR - 20220531 IS - 2296-2565 (Electronic) IS - 2296-2565 (Linking) VI - 9 DP - 2021 TI - Antimicrobial Resistance Profiles of Coagulase-Negative Staphylococci in Community-Based Healthy Individuals in Germany. PG - 684456 LID - 10.3389/fpubh.2021.684456 [doi] LID - 684456 AB - Coagulase-negative staphylococci (CoNS) are common opportunistic pathogens, but also ubiquitous human and animal commensals. Infection-associated CoNS from healthcare environments are typically characterized by pronounced antimicrobial resistance (AMR) including both methicillin- and multidrug-resistant isolates. Less is known about AMR patterns of CoNS colonizing the general population. Here we report on AMR in commensal CoNS recovered from 117 non-hospitalized volunteers in a region of Germany with a high livestock density. Among the 69 individuals colonized with CoNS, 29 had reported contacts to either companion or farm animals. CoNS were selectively cultivated from nasal swabs, followed by species definition by 16S rDNA sequencing and routine antibiotic susceptibility testing. Isolates displaying phenotypic AMR were further tested by PCR for presence of selected AMR genes. A total of 127 CoNS were isolated and Staphylococcus epidermidis (75%) was the most common CoNS species identified. Nine isolates (7%) were methicillin-resistant (MR) and carried the mecA gene, with seven individuals (10%) being colonized with at least one MR-CoNS isolate. While resistance against gentamicin, phenicols and spectinomycin was rare, high resistance rates were found against tetracycline (39%), erythromycin (33%) and fusidic acid (24%). In the majority of isolates, phenotypic resistance could be associated with corresponding AMR gene detection. Multidrug-resistance (MDR) was observed in 23% (29/127) of the isolates, with 33% (23/69) of the individuals being colonized with MDR-CoNS. The combined data suggest that MR- and MDR-CoNS are present in the community, with previous animal contact not significantly influencing the risk of becoming colonized with such isolates. CI - Copyright (c) 2021 Marincola, Liong, Schoen, Abouelfetouh, Hamdy, Wencker, Marciniak, Becker, Kock and Ziebuhr. FAU - Marincola, Gabriella AU - Marincola G AD - Institute of Molecular Infection Biology, University of Wurzburg, Wurzburg, Germany. FAU - Liong, Olivia AU - Liong O AD - Institute of Molecular Infection Biology, University of Wurzburg, Wurzburg, Germany. FAU - Schoen, Christoph AU - Schoen C AD - Institute of Hygiene and Microbiology, University of Wurzburg, Wurzburg, Germany. FAU - Abouelfetouh, Alaa AU - Abouelfetouh A AD - Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. AD - Department of Microbiology and Immunology, Faculty of Pharmacy, AlAlamein International University, AlAlamein, Egypt. FAU - Hamdy, Aisha AU - Hamdy A AD - Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. FAU - Wencker, Freya D R AU - Wencker FDR AD - Institute of Molecular Infection Biology, University of Wurzburg, Wurzburg, Germany. FAU - Marciniak, Tessa AU - Marciniak T AD - Institute of Molecular Infection Biology, University of Wurzburg, Wurzburg, Germany. AD - Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Wurzburg, Germany. FAU - Becker, Karsten AU - Becker K AD - Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany. FAU - Kock, Robin AU - Kock R AD - Deutsches Rotes Kreuz (DRK) Kliniken Berlin, Berlin, Germany. AD - Institute of Hygiene, University Hospital Munster, Munster, Germany. FAU - Ziebuhr, Wilma AU - Ziebuhr W AD - Institute of Molecular Infection Biology, University of Wurzburg, Wurzburg, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210617 PL - Switzerland TA - Front Public Health JT - Frontiers in public health JID - 101616579 RN - 0 (Anti-Bacterial Agents) RN - 0 (Coagulase) SB - IM MH - Animals MH - Anti-Bacterial Agents/pharmacology MH - Coagulase/genetics MH - *Drug Resistance, Bacterial/genetics MH - Germany/epidemiology MH - Humans MH - *Staphylococcal Infections/drug therapy PMC - PMC8247762 OTO - NOTNLM OT - Germany OT - One Health OT - antimicrobial resistance OT - coagulase-negative staphylococci OT - community settings COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/07/06 06:00 MHDA- 2021/08/05 06:00 PMCR- 2021/06/17 CRDT- 2021/07/05 10:14 PHST- 2021/03/23 00:00 [received] PHST- 2021/05/24 00:00 [accepted] PHST- 2021/07/05 10:14 [entrez] PHST- 2021/07/06 06:00 [pubmed] PHST- 2021/08/05 06:00 [medline] PHST- 2021/06/17 00:00 [pmc-release] AID - 10.3389/fpubh.2021.684456 [doi] PST - epublish SO - Front Public Health. 2021 Jun 17;9:684456. doi: 10.3389/fpubh.2021.684456. eCollection 2021.